Trial of the Effectiveness of a Nurse Education and Care Program for Breast Cancer Patients Treated With Chemotherapy
Randomized Trial of the Effectiveness of a Nurse Education and Care Program for Breast Cancer Patients Treated With Chemotherapy
1 other identifier
interventional
266
1 country
1
Brief Summary
The purpose of this study is to evaluate the effects of a nurse education and care program for patients with breast cancer, in terms of use of the health services, quality of life, satisfaction and security. Hypothesis: Nurse education and care program will reduce the use of health resources and will improve the toxicity, quality of life and satisfaction of the patients with breast cancer who initiate chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Jan 2007
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 17, 2009
CompletedFirst Posted
Study publicly available on registry
August 25, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedJune 22, 2011
April 1, 2010
4.2 years
August 17, 2009
June 21, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Use of health resources (not programmed attendance in Primary, Specialist and Emergency care or hospitalisation).
one year
Secondary Outcomes (3)
Toxicity.
one year
Quality of life.
one year
Satisfaction
one year
Study Arms (2)
Standard care
NO INTERVENTIONThe arm A is the one of standard education and care.
Nurse education and care program
ACTIVE COMPARATORThe arm B will receive programmed education and care about the chemotherapy by a nurse of the Medical Oncology service before the beginning of the treatment and in each cycle, in a specific nurse consultation.
Interventions
Random allocation of the patients in two arms according to the nursing cares. The arm A is the one of standard education and care. They consist of receiving programmed oral and written information by the specialist before initiating the chemotherapy treatment and before each cycle of treatment. Also, the patients will be able to ask for information to the nurses when they need it. Arm B is the one of experimental education and care. They consist of receiving oral and written information by the specialist before initiating the chemotherapy treatment and before each cycle. In addition, the patients assigned to arm B will receive programmed education and care about the chemotherapy by a Oncology nurse before the beginning of the treatment and in each cycle, in a specific nurse consultation.
Eligibility Criteria
You may qualify if:
- Patients with breast cancer who initiate adjuvant, neoadjuvant or palliative chemotherapy.
- Performance status 0-2 (ECOG).
- Outpatients.
- Normal hematopoietic, hepatic, renal, cardiac and lung functions.
- Must be able to sign the informed consent
You may not qualify if:
- Contraindication for chemotherapy
- Inpatients
- Simultaneously radiotherapy and endocrine therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Instituto de Salud Carlos IIIlead
- Health Service of Andaluciacollaborator
Study Sites (1)
Oncology Unit, Hospital Universitario Puerta del Mar
Cadiz, Andalusia, 11009, Spain
Related Publications (1)
Baena-Canada JM, Estalella-Mendoza S, Gonzalez-Guerrero M, Exposito-Alvarez I, Rosado-Varela P, Benitez-Rodriguez E. [Influence of clinical and biographical factors on the quality of life of women with breast cancer receiving adjuvant chemotherapy]. Rev Calid Asist. 2011 Sep-Oct;26(5):299-305. doi: 10.1016/j.cali.2011.04.005. Epub 2011 Sep 16. Spanish.
PMID: 21925913DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
José M. Baena-Cañada, MD; PhD
Oncology Unit, Hospital Universitario Puerta del Mar, Cádiz, Spain
- PRINCIPAL INVESTIGATOR
Macarena González-Muñoz, Nurse
Oncology Unit, Hospital Universitario Puerta del Mar, Cádiz, Spain
- PRINCIPAL INVESTIGATOR
Lourdes Solana-Grimaldi, Nurse
Oncology Unit, Hospital Universitario Puerta del Mar, Cádiz, Spain
- PRINCIPAL INVESTIGATOR
María D. González Piney, Nurse
Oncology Unit, Hospital Universitario Puerta del Mar, Cádiz, Spain
- PRINCIPAL INVESTIGATOR
Esperanza Arriola-Arellano, MD
Oncology Unit, Hospital Universitario Puerta del Mar, Cádiz, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
August 17, 2009
First Posted
August 25, 2009
Study Start
January 1, 2007
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
June 22, 2011
Record last verified: 2010-04